ENG and acute myeloid leukemia: Besides solid tumors, CD105 is also expressed in primary human leukemic blasts (36.9%) [7], and CD105 high expression correlates with poor prognosis in AML [8], suggesting that this receptor may also represent a potential target for hematopoietic malignancies.